Micaela Hernberg

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “SAKK 35/14 RANDOMIZED TRIAL OF RITUXIMAB WITH OR WITHOUT IBRUTINIB FOR UNTREATED PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA IN NEED OF THERAPY”.

SAKK 35/14 RANDOMIZED TRIAL OF RITUXIMAB WITH OR WITHOUT IBRUTINIB FOR UNTREATED PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA IN NEED OF THERAPY

Hematological Oncology(2023)10.1002/hon.3163_80

N/A

0DataRank · unranked

3 citations

Maria Cristina Pirosa, Sämi Schär, Marianne Brodtkorb, Björn E. Wahlin, Micaela Hernberg +19 more

Health-related Quality of Life and hospital costs of Finnish melanoma patients participating in the second Multicenter Selective Lymphadenectomy Trial (MSLT-II)

Acta Oncologica(2025)10.2340/1651-226x.2025.42314

N/A

0DataRank · unranked

1 citations

Jukka Pappinen, John F. Thompson, Micaela Hernberg, Tiina Jahkola, Mark B. Faries +1 more